An FDA deficiency letter isn't a rejection, but a disorganized non-targeted response can function like one. Here's a strategic framework for responding without stalling your review.
The PreSTAR template ensures structural compliance, but structure alone won’t get you substantive FDA feedback. Here’s how to build a Pre-Sub that helps shape your regulatory strategy.
